In addition, an analysis of The Cancer Genome Atlas (TCGA) database revealed that low expression levels of C6orf141 were associated with a poor survival rate in patients with breast cancer, endometrial cancer, and head and neck cancer12. The gene discussed is C6orf141; the disease is breast cancer.